Procept BioRobotics Corp (NASDAQ:PRCT) has a beta value of 1.00 and has seen 1.08 million shares traded in the last trading session. The company, currently valued at $5.28B, closed the last trade at $97.07 per share which meant it gained $4.78 on the day or 5.18% during that session. The PRCT stock price is -2.34% off its 52-week high price of $99.34 and 71.52% above the 52-week low of $27.65. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.69 million shares traded. The 3-month trading volume is 857.35K shares.
The consensus among analysts is that Procept BioRobotics Corp (PRCT) is Buy stock at the moment, with a recommendation rating of 1.25. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.34.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Procept BioRobotics Corp (NASDAQ:PRCT) trade information
Sporting 5.18% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the PRCT stock price touched $97.07 or saw a rise of 2.29%. Year-to-date, Procept BioRobotics Corp shares have moved 131.62%, while the 5-day performance has seen it change 6.67%. Over the past 30 days, the shares of Procept BioRobotics Corp (NASDAQ:PRCT) have changed 33.59%. Short interest in the company has seen 6.71 million shares shorted with days to cover at 10.14.
Wall Street analysts have a consensus price target for the stock at $75, which means that the shares’ value could drop -29.43% from current levels. The projected low price target is $49.0 while the price target rests at a high of $105.0. In that case, then, we find that the current price level is -8.17% off the targeted high while a plunge would see the stock lose 49.52% from current levels.
Procept BioRobotics Corp (PRCT) estimates and forecasts
Figures show that Procept BioRobotics Corp shares have outperformed across the wider relevant industry. The company’s shares have gained 58.02% over the past 6 months, with this year growth rate of 22.32%, compared to 14.70% for the industry. Revenue growth from the last financial year stood is estimated to be 63.80%.
7 analysts offering their estimates for the company have set an average revenue estimate of 66.84M for the current quarter. 6 have an estimated revenue figure of 66.33M for the next ending quarter. Year-ago sales stood 43.58M and 44.54M respectively for this quarter and the next, and analysts expect sales will grow by 53.40% for the current quarter and 63.80% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -23.27% over the past 5 years. Earnings growth for 2024 is a modest 21.48% while over the next 5 years, the company’s earnings are expected to increase by 23.10%.
PRCT Dividends
Procept BioRobotics Corp is expected to release its next earnings report in December this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Procept BioRobotics Corp (NASDAQ:PRCT)’s Major holders
Insiders own 4.70% of the company shares, while shares held by institutions stand at 84.20% with a share float percentage of 88.36%. Investors are also buoyed by the number of investors in a company, with Procept BioRobotics Corp having a total of 317.0 institutions that hold shares in the company. The top two institutional holders are FMR LLC with over 7.29 million shares worth more than $445.33 million. As of 2024-06-30, FMR LLC held 14.2907% of shares outstanding.
The other major institutional holder is VANGUARD GROUP INC, with the holding of over 4.71 million shares as of 2024-06-30. The firm’s total holdings are worth over $287.87 million and represent 9.2375% of shares outstanding.
